11/22/24 16:11 | 11/20/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -85 | 25.45 | 0 | -3 | -1 | 362 | D | | | | | | | | | | | | | | |
10/18/24 16:30 | 10/16/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -92 | 28.79 | 0 | -3 | -1 | 365 | D | | | | | | | | | | | | | | |
8/23/24 16:14 | 8/21/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -96 | 31.86 | 0 | -3 | -1 | 368 | D | | | | | | | | | | | | | | |
7/19/24 17:41 | 7/17/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -90 | 29.69 | 0 | -3 | -1 | 371 | D | | | | | | | | | | | | | | |
5/24/24 16:13 | 5/22/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -96 | 29.65 | 0 | -3 | -1 | 374 | D | | | | | | | | | | | | | | |
4/19/24 18:05 | 4/17/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -241 | 29.06 | 0 | -8 | -2 | 378 | D | | | | | | | | | | | | | | |
2/23/24 16:16 | 2/22/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -80 | 36.15 | 0 | -2 | -1 | 331 | D | | | | | | | | | | | | | | |
1/19/24 16:04 | 1/18/24 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -17 | 41.03 | 0 | 0 | 0 | 333 | D | | | | | | | | | | | | | | |
11/24/23 14:45 | 11/22/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -107 | 32.78 | 0 | -3 | -1 | 334 | D | | | | | | | | | | | | | | |
10/20/23 16:06 | 10/19/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -20 | 36.80 | 0 | -1 | 0 | 337 | D | | | | | | | | | | | | | | |
8/25/23 16:57 | 8/24/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -250 | 20.30 | 0 | -12 | -4 | 337 | D | | | | | | | | | | | | | | |
7/20/23 16:37 | 7/19/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -11 | 24.94 | 0 | 0 | 0 | 350 | D | | | | | | | | | | | | | | |
4/26/23 16:12 | 4/25/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -8 | 16.29 | 0 | -1 | 0 | 350 | D | | | | | | | | | | | | | | |
2/3/23 07:24 | 2/2/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -10 | 18.24 | 0 | -1 | 0 | 263 | D | | | | | | | | | | | | | | |
1/13/23 08:13 | 1/11/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -746 | 16.75 | 0 | -45 | -14 | 264 | D | | | | | | | | | | | | | | |
10/25/22 07:43 | 10/21/22 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -3 | 9.67 | 0 | 0 | 0 | 308 | D | | | | | | | | | | | | | | |
7/26/22 07:35 | 7/22/22 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -2 | 4.70 | 0 | 0 | 0 | 196 | D | | | | | | | | | | | | | | |
4/20/22 16:34 | 4/19/22 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -7 | 4.98 | 0 | -1 | -1 | 196 | D | | | | | | | | | | | | | | |
1/7/22 12:39 | 1/5/22 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | S | -222 | 8.28 | 0 | -27 | -12 | 197 | D | | | | | | | | | | | | | | |